Basics Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. IPO Date: September 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $250.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.50% Avg Daily Range (30 D): $0.22 | 2.69% Avg Daily Range (90 D): $0.20 | 2.56% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.82M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.2M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 755.98K     News Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A Feb 7, 2025 @ 12:00 PM Fennec Pharmaceuticals Announces Commercial Launch... Source: Fennec Pharmaceuticals Inc. Jul 1, 2024 @ 10:00 AM Fennec Pharmaceuticals Announces Management Change... Source: Fennec Pharmaceuticals Inc. Jun 25, 2024 @ 8:35 PM Fennec Announces Results of Annual Meeting Source: Fennec Pharmaceuticals Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.44 $-.11 $-.04 Diluted EPS $-.44 $-.11 $-.04 Revenue $ 33.3M $ 9.65M $ 8.75M Gross Profit $ $ $ Net Income / Loss $ -12.04M $ -3.15M $ -1.17M Operating Income / Loss $ -9.68M $ -2.73M $ -.81M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Sep 05, 2014:   1:3 Aug 30, 2011:   1:18 Aug 02, 2005:   1:5